Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-05-17 @ 4:09 PM
Study NCT ID:
NCT06211335
Status:
RECRUITING
Last Update Posted:
2025-04-18
First Post:
2024-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
Sponsor:
Shyam S.D. Rao
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCDCC311
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |